Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature
Abstract Background TMPRSS2-ERG (T2E) fusion is highly related to aggressive clinical features in prostate cancer (PC), which guides individual therapy. However, current fusion prediction tools lacked enough accuracy and biomarkers were unable to be applied to individuals across different platforms...
Main Authors: | Yawei Li, Hang Su, Kaidong Liu, Zhangxiang Zhao, Yuquan Wang, Bo Chen, Jie Xia, Huating Yuan, De-Shuang Huang, Yunyan Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-024-03314-8 |
Similar Items
-
PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
by: Jack A. Schalken, et al.
Published: (2010-07-01) -
PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
by: Warli SM, et al.
Published: (2023-05-01) -
Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
by: Francesca Giunchi, et al.
Published: (2020-12-01) -
Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2023-05-01) -
Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2021-06-01)